Sequent Scientific and Viyash Life Sciences have announced a merger that will result in the two companies forming a combination that will create a platform with leadership in animal pharmaceuticals, end-to-end integrated capabilities across the larger global pharmaceutical market with a strong operating and research and development backbone, according to a stock exchange filing.
